Results 231 to 240 of about 4,259,087 (330)

Advances in Multidimensional Molecular Mechanisms of Epilepsy and Precision Therapy Strategies

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Epilepsy arises from a multidimensional network imbalance, integrating genetic, inflammatory, and metabolic disruptions. This complexity drives neuronal hyperexcitability and underpins therapeutic challenges. Our review highlights how emerging precision strategies, from targeted molecular therapies to neuromodulation, offer a transformative path toward
Yimin Han   +7 more
wiley   +1 more source

A short overview of dual targeting HDAC inhibitors. [PDF]

open access: yesFuture Med Chem
Liu WB, Song J, Zhang SY.
europepmc   +1 more source

Morinda Officinalis Oligosaccharides Alleviate Post‐Stroke Depression‐Like Behaviors Alongside Increased Gut Microbial Diversity and Butyrate Levels and Reduced Hippocampal Pla2g4a Expression

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
The mechanism by which MOO alleviates PSD in mice involves remodeling the gut microbiota to increase butyrate, thereby repairing the intestinal barrier and the blood–brain barrier. MOO and butyrate downregulate the hippocampal neuroinflammatory target Pla2g4a, while hippocampal overexpression of Pla2g4a counteracts the antidepressant effects of ...
Hui Ma   +11 more
wiley   +1 more source

HDAC inhibitors engage MITF and the disease-associated microglia signature to enhance amyloid β uptake. [PDF]

open access: yesBrain Behav Immun
Haage V   +18 more
europepmc   +1 more source

Empirical PK/PD Model for Differentiating Intrinsic Dosing Rules by Therapeutic Indication With Relevance for HIV‐1 Latency Reversal

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1414-1426, November 2026.
Romidepsin (RMD), an FDA‐approved histone deacetylase inhibitor for treating cancer, demonstrates potent latency‐reversing activity in vitro but has yielded suboptimal outcomes in kick‐and‐kill HIV‐cure trials when administered as a 5 mg/m2 infusion.
Lauren A. R. Tompkins   +7 more
wiley   +1 more source

Dose-dependent dual effects of HDAC inhibitors on glial inflammatory response. [PDF]

open access: yesSci Rep
Mancino S   +6 more
europepmc   +1 more source

The microbiome and brain metastasis in non‐small cell lung cancer: A graded appraisal and a framework for prevention‐oriented research

open access: yesClinical and Translational Medicine, Volume 16, Issue 11, November 2026.
This Review proposes a microbiome–premetastatic brain niche axis connecting gut, lung, and intratumoral microbes with metabolites, blood–brain barrier remodeling, neuroimmune priming, and brain metastasis in NSCLC. It integrates current evidence while distinguishing established mechanisms from associations and hypotheses requiring prospective and ...
Long Liang   +8 more
wiley   +1 more source

HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation‐induced lung injury

open access: yesClinical and Translational Medicine, Volume 16, Issue 11, November 2026.
HDAC3 promotes radiation‐induced lung injury by deacetylating MKP1 and activating the p38/c‐Fos/AP‐1 signalling axis, leading to excessive inflammatory responses and alveolar epithelial barrier dysfunction. Targeting HDAC3 with genetic deletion or RGFP966‐mediated inhibition effectively alleviates lung injury, supporting HDAC3 as a promising ...
Boyang Li   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy